Viewing Study NCT00645502


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2025-12-26 @ 2:21 AM
Study NCT ID: NCT00645502
Status: COMPLETED
Last Update Posted: 2010-04-26
First Post: 2008-03-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module